Comparative Assessment of Adherence Parameters to Urate-Lowering Therapy in Patients With Gout

Abstract

The study aims to evaluate adherence to urate-lowering therapy (ULT) among patients with gout, to identify factors influencing adherence, and to compare the efficacy and tolerability of allopurinol and febuxostat. A total of 60 patients with a verified gout diagnosis were examined. Adherence was assessed using the Morisky–Green scale. The results demonstrated that more than half of the patients had low or moderate adherence, associated with insufficient awareness and irregular follow-up. Febuxostat showed higher treatment adherence and better achievement of target serum uric acid levels compared with allopurinol. Improving patient education and monitoring is essential for effective gout management.